Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Not yet recruiting 2Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Breast Neoplasms 3Prostatic Neoplasms 2Tooth, Impacted 1Sleep Initiation and Maintenance Disorders 1Resectable Colorectal Carcinoma 1Nocturia 1Multiple Myeloma 1Lymphoma, Non-Hodgkin 1Hodgkin Disease 1Colorectal Neoplasms 1Carcinoma, Non-Small-Cell Lung 1Cancer Pain 1Agnosia 1

Interventions

Carboplatin 85pembrolizumab 78Pemetrexed 68Cisplatin 56Paclitaxel 45osimertinib 41Nivolumab 41durvalumab 39Docetaxel 34atezolizumab 20Gemcitabine 18Radiotherapy 17Radiosurgery 16amivantamab 15Ipilimumab 15130-nm albumin-bound paclitaxel 14Taxes 13Specimen Handling 12Magnetic Resonance Spectroscopy 12Crizotinib 11lazertinib 9Radiation 9Immunoglobulin G 9Drug Therapy 9Disulfides 9Bevacizumab 9tislelizumab 8cemiplimab 8alectinib 8Erlotinib Hydrochloride 8

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Active not recruiting × Carcinoma, Non-Small-Cell Lung × Acupuncture Therapy × Clear all
NCT06461338 2025-12-17

Acupuncture for Enhancing Immunotherapy in Advanced NSCLC:a Pilot Study

Guangzhou University of Traditional Chinese Medicine

Phase NA Active not recruiting
60 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon âš¡